16 Tumor growth inhibition mediated by a single dose of intratumoral TransCon™ TLR7/8 agonist was associated with activated circulating T and B cells and sustained low levels of systemic cytokines

Bibliographic Details
Title: 16 Tumor growth inhibition mediated by a single dose of intratumoral TransCon™ TLR7/8 agonist was associated with activated circulating T and B cells and sustained low levels of systemic cytokines
Authors: Amer Mirza, David Rosen, Juha Punnonen, Enping Hong, Luis Zuniga, Karan Uppal, Kathy Bang, Simran Sabharwal, Yuchi Lee, Salomon Martinez
Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Publisher Information: BMJ Publishing Group, 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2021-SITC2021.016
Access URL: https://doaj.org/article/ab51cf4acb4a48fda431edd435e3dc09
Accession Number: edsdoj.b51cf4acb4a48fda431edd435e3dc09
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2021-SITC2021.016
Published in:Journal for ImmunoTherapy of Cancer
Language:English